A case series of BRAF V600E inhibitor (PLX4032) related cutaneous eruptions in metastatic melanoma

被引：0
|
作者：
Sinha, R. [1 ]
Fearfield, L. [2 ]
Larkin, J. [1 ]
机构：
[1] Chelsea & Westminster Hosp NHS Fdn Trust, London, England
[2] Royal Marsden NHS Fdn Trust, London, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2011年 / 165卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [31] Putative genomic characteristics of BRAF V600K versus V600E cutaneous melanoma
    Li, Yuanyuan
    Umbach, David M.
    Li, Leping
    MELANOMA RESEARCH, 2017, 27 (06) : 527 - 535
  • [32] The impact of BRAF V600E mutation status discordance between primary cutaneous melanoma and metastatic brain lesions: The clinical implications for BRAF inhibitor therapy
    Hannan, E.
    O'Leary, D. P.
    Farrell, M.
    McNally, S.
    Hill, A. D. K.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S94 - S94
  • [33] Induction of apoptosis by the BRAFV600E kinase inhibitor PLX4032 in BRAFV600E melanoma cells through regulation of endoplasmic reticulum stress-related genes
    Meier, F. E.
    Beck, D.
    Niessner, H.
    Flaherty, K. T.
    Iovanna, J.
    Kulms, D.
    Schadendorf, D.
    Garbe, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [34] Prevalence of BRAF V600E mutation in metastatic melanoma of Mexican Mestizo population
    Ruiz-Garcia, E.
    Meneses, A.
    Martinez-Said, H.
    Aguilar-Ponce, J. L.
    Mohar, A.
    Lopez, A.
    Alonso-Luna, O.
    Guadarrama-Orozco, J. A.
    Green, D.
    Astudillo-de la Vega, H.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S875 - S875
  • [35] The MEK1/2 Inhibitor AS703026 Circumvents Resistance to the BRAF Inhibitor PLX4032 in Human Malignant Melanoma Cells
    Park, Seong Joon
    Hong, Seung-Woo
    Moon, Jai-Hee
    Jin, Dong-Hoon
    Kim, Jin-Sun
    Lee, Chang-Kyu
    Kim, Kyu-pyo
    Hong, Yong Sang
    Choi, Eun Kyung
    Lee, Jung Shin
    Lee, Jae-Lyun
    Kim, Tae Won
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2013, 346 (06): : 494 - 498
  • [36] Immunohistochemical BRAF V600E Expression and Intratumor BRAF V600E Heterogeneity in Acral Melanoma: Implication in Melanoma-Specific Survival
    Ito, Takamichi
    Kaku-Ito, Yumiko
    Murata, Maho
    Furue, Kazuhisa
    Shen, Che-Hung
    Oda, Yoshinao
    Furue, Masutaka
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
  • [37] A Case of Giant Primary Dermal Melanoma with BRAF V600E Mutation
    Imamura, Taichi
    Nakamura, Yasuhiro
    Teramoto, Yukiko
    Sato, Sayuri
    Asami, Yuri
    Arai, Eiichi
    Yamamoto, Akifumi
    ACTA DERMATO-VENEREOLOGICA, 2016, 96 (06) : 840 - 841
  • [38] RG7204 (PLX4032), a Selective BRAFV600E Inhibitor, Displays Potent Antitumor Activity in Preclinical Melanoma Models
    Yang, Hong
    Higgins, Brian
    Kolinsky, Kenneth
    Packman, Kathryn
    Go, Zenaida
    Iyer, Raman
    Kolis, Stanley
    Zhao, Sylvia
    Lee, Richard
    Grippo, Joseph F.
    Schostack, Kathleen
    Simcox, Mary Ellen
    Heimbrook, David
    Bollag, Gideon
    Su, Fei
    CANCER RESEARCH, 2010, 70 (13) : 5518 - 5527
  • [39] V600E mutations in metastatic melanoma: Case report.
    Inic, Momcilo
    Inic, Zorka Momcilo
    Zegarac, Milan
    Pupic, Gordana
    Inic, Ivana
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [40] Dabrafenib in advanced melanoma with BRAF V600E mutation
    Abraham, Jame
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2014, 12 (02): : 48 - 49
12345